Sertraline to treat hot flashes: A randomized controlled, double-blind, crossover trial in a general population

Menopause

Volumn 13, Issue 4, 2006, Pages 568-575

  Gordon, Paul R ^a,b   Kerwin, James P ^a   Boesen, Kelly Green ^a   Senf, Janet ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Hot flashes; Menopause; Selective serotonin reuptake inhibitor

Indexed keywords

PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HORMONAL THERAPY; HOT FLUSH; HUMAN; LIBIDO; MAJOR CLINICAL STUDY; NAUSEA; POPULATION; RANDOMIZED CONTROLLED TRIAL; SEXUAL FUNCTION; URBAN AREA;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HOT FLASHES; HUMANS; MENOPAUSE; MIDDLE AGED; SERTRALINE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33746102870     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gme.0000196595.82452.ca     Document Type: Article

References (32)

1. Kronenberg F. Hot flashes: epidemiology and physiology. Ann N Y Acad Sci 1990;592:52-86.
2. Bureau UC. Profile of General Demographic Characteristics for the United States: 2000. Available at: http://www.census.gov/Press-Release/www/2001/ demoprofile.htmlpleasepls. Accessed November 1, 2005.
3. Bachmann GA. Vasomotor flushes in menopausal women. Am J Obstet Gynecol 1999;180:S312-S316.
4. Kronenberg F. Hot flashes: phenomenology, quality of life, and search for treatment options. Exp Gerontol 1994;29:319-336.
5. Gold EB, Block G, Crawford S, et al. Lifestyle and demographic factors in relation to vasomotor symptoms: baseline results from the Study of Women's Health Across the Nation. Am J Epidemiol 2004;159:1189-1199.
6. Kravitz HM, Ganz PA, Bromberger J, Powell LH, Sutton-Tyrrell K, Meyer PM. Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause 2003;10:19-28.
7. Avis NE, Stellato R, Crawford S, et al. Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Soc Sci Med 2001;52:345-356.
8. Gass ML, Taylor MB. Alternatives for women through menopause. Am J Obstet Gynecol 2001;185(2 Suppl):S47-S56.
9. Evans ML, Pritts E, Vittinghoff E, McClish K, Morgan KS, Jaffe RB. Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial. Obstet Gynecol 2005;105:161-166.
10. Writing Group for the Women's Health Initiative I. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
11. Bair YA, Gold EB, Greendale GA, et al. Ethnic differences in use of complementary and alternative medicine at midlife: longitudinal results from SWAN participants. Am J Public Health 2002;92:1832-1840.
12. Goldberg RM, Loprinzi CL, O'Fallon JR, et al. Transdermal clonidine for ameliorating tamoxifen-induced hot flashes. J Clin Oncol 1994;12:155-158.
13. Eichholz AC, Mahavni V, Sood AK. Allopathic and complementary alternatives to hormone replacement therapy. Expert Opin Pharmacother 2002;3:949-955.
14. Fitzpatrick LA. Alternatives to estrogen. Med Clin North Am 2003;87:1091-1113.
15. Barton D, Loprinzi CL. Making sense of the evidence regarding nonhormonal treatments for hot flashes. Clin J Oncol Nurs 2004;8:39-42.
16. Gottlieb N. Nonhormonal agents show promise against hot flashes. J Natl Cancer Inst 2000;92:1118-1120.
17. Loprinzi CL, Kugler JW, Sloan JA, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 2000;356:2059-2063.
18. Barlow DH. Venlafaxine for hot flushes. Lancet 2000;356:2025-2026.
19. Loprinzi CL, Sloan JA, Perez EA, et al. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol 2002;20:1578-1583.
20. Weitzner MA, Moncello J, Jacobsen PB, Minton S. A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer. J Pain Sympt Manage 2002;23:337-345.
21. Stearns V, Isaacs C, Rowland J, et al. A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors. Ann Oncol 2000;11:17-22.
22. Stearns V, Hayes DF. Approach to menopausal symptoms in women with breast cancer. Curr Treat Options Oncol 2002;3:179-190.
23. Stearns V, Beebe KL, Iyengar M, Dube E. Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial. JAMA 2003;289:2827-2834.
24. Nagata H, Nozaki M, Nakano H. Short-term combinational therapy of low-dose estrogen with selective serotonin re-uptake inhibitor (fluvoxamine) for oophorectomized women with hot flashes and depressive tendencies. J Obstet Gynaecol Res 2005;31:107-114.
25. De Sloover Koch Y, Ernst ME. Selective serotonin-reuptake inhibitors for the treatment of hot flashes. Ann Pharmacother 2004:1293-1296.
26. Hlatky MA, Boothroyd D, Vittinghoff E, Sharp P, Whooley MA. Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial. JAMA 2002;287:591-597.
27. Hlatky MA, Boineau RE, Higginbotham MB, et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol 1989;64:651-654.
28. Stewart AL, Hays RD, Ware JEJ. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 1998;26:724-735.
29. Burnam MA, Wells KB, Leake B, Landsverk J. Development of a brief screening instrument for detecting depressive disorders. Med Care 1988;26:775-789.
30. Loprinzi CL, Pisansky TM, Fonseca R, et al. Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. J Clin Oncol 1998;16:2377-2381.
31. Roth AJ, Scher HI. Sertraline relieves hot flashes secondary to medical castration as treatment of advanced prostate cancer. Psychooncology 1998;7:129-132.
32. Kimmick GG, McQuellon LJ, et al. Randomized placebo-controlled study of sertraline for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen. Proc Am Soc Clin Oncol 2001;20:1585a.